AbbVie, Inc. (ABBV)
285.64
+0.45
(+0.16%)
USD |
NYSE |
Oct 23, 16:00
285.27
-0.37
(-0.13%)
After-Hours: 20:00
AbbVie Price : 285.64 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 284.58 | 286.76 | 282.30 | 285.64 | 4.632M |
| Oct 22, 2026 | 284.57 | 285.76 | 278.01 | 285.19 | 6.173M |
| Oct 21, 2026 | 287.63 | 289.00 | 282.15 | 284.80 | 4.395M |
| Oct 20, 2026 | 286.90 | 290.98 | 285.00 | 289.08 | 5.176M |
| Oct 19, 2026 | 284.23 | 287.93 | 282.59 | 282.68 | 4.172M |
| Oct 16, 2026 | 283.61 | 286.64 | 282.96 | 285.42 | 5.777M |
| Oct 15, 2026 | 288.28 | 291.40 | 282.81 | 283.40 | 7.622M |
| Oct 14, 2026 | 277.00 | 285.40 | 275.97 | 283.48 | 5.633M |
| Oct 13, 2026 | 283.29 | 283.43 | 273.70 | 274.36 | 6.410M |
| Oct 12, 2026 | 277.65 | 281.30 | 276.01 | 281.12 | 5.594M |
| Oct 09, 2026 | 271.53 | 277.60 | 270.38 | 276.47 | 4.298M |
| Oct 08, 2026 | 270.98 | 272.52 | 265.71 | 272.42 | 5.495M |
| Oct 07, 2026 | 268.40 | 274.94 | 266.89 | 271.36 | 6.079M |
| Oct 06, 2026 | 267.74 | 268.86 | 260.62 | 266.69 | 4.501M |
| Oct 05, 2026 | 261.27 | 267.34 | 260.29 | 265.76 | 7.545M |
| Oct 02, 2026 | 259.74 | 264.06 | 257.87 | 262.82 | 5.863M |
| Oct 01, 2026 | 260.51 | 262.32 | 259.00 | 259.93 | 3.892M |
| Sep 30, 2026 | 264.60 | 265.36 | 261.59 | 261.59 | 4.389M |
| Sep 29, 2026 | 265.45 | 268.93 | 261.52 | 263.29 | 4.004M |
| Sep 28, 2026 | 264.33 | 267.74 | 263.38 | 266.28 | 4.430M |
| Sep 25, 2026 | 265.49 | 266.00 | 262.59 | 264.34 | 2.542M |
| Sep 24, 2026 | 265.37 | 267.41 | 263.09 | 265.12 | 3.458M |
| Sep 23, 2026 | 266.00 | 269.39 | 263.59 | 265.08 | 3.469M |
| Sep 22, 2026 | 263.10 | 266.82 | 262.14 | 265.21 | 2.766M |
| Sep 21, 2026 | 263.07 | 266.60 | 261.23 | 264.48 | 3.438M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 156.04 |
| Biogen, Inc. | 250.69 |
| Amgen, Inc. | 439.26 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
| REGENXBIO, Inc. | 6.68 |
Price Related Metrics
| PE Ratio | 80.76 |
| PS Ratio | 7.865 |
| PEG Ratio | 1.182 |
| Price to Free Cash Flow | 27.81 |
| Earnings Yield | 1.24% |
| Market Cap | 504.75B |
| PEGY Ratio | 1.142 |
| Operating PE Ratio | 23.01 |
| Normalized PE Ratio | 35.48 |